Literature DB >> 1889456

Hemolytic anemia in non-obese diabetic mice.

A G Baxter1, T E Mandel.   

Abstract

The non-obese diabetic mouse (NOD mouse) is widely used as a model of organ-specific autoimmunity because it develops specific autoimmune destruction of pancreatic beta cells mediated by T cells and culminating in insulin-dependent diabetes mellitus. Here, we report that the NOD mouse also develops Coombs'-positive hemolytic anemia, a B cell-mediated autoimmune disease. Aged NOD mice were found to have splenomegaly and jaundice predominantly due to raised unconjugated serum bilirubin. Their hematocrits were markedly lowered, and there was a reciprocal increase in the reticulocyte count. Red blood cells (RBC) from anemic mice showed a normal lytic response to hypotonicity. RBC from non-anemic mice had normal half lives in non-anemic, non-diabetic NOD mice by 51Cr labeling but, dramatically shortened half lives in anemic mice. Similar results were obtained with RBC from anemic mice. Hemolysis could be transferred with serum from anemic mice resulting in reticulocytosis. The antibody-mediated nature of the anemia was confirmed with the direct Coombs' test. Anemia was found only in mice aged greater than 200 days and was more common in diabetic (4/8) than non-diabetic (1/16) mice at 300 days. However, by 550 days, 14/17 non-diabetic mice were affected.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1889456     DOI: 10.1002/eji.1830210912

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

Review 1.  Polyspecificity of autoimmune responses in type 1 (autoimmune) diabetes.

Authors:  L M Esteban; A G Baxter
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

Review 2.  Use of mouse models to study the mechanisms and consequences of RBC clearance.

Authors:  E A Hod; S A Arinsburg; R O Francis; J E Hendrickson; J C Zimring; S L Spitalnik
Journal:  Vox Sang       Date:  2010-03-21       Impact factor: 2.144

Review 3.  Lessons learned from mouse models of hemolytic transfusion reactions.

Authors:  Eldad A Hod; James C Zimring; Steven L Spitalnik
Journal:  Curr Opin Hematol       Date:  2008-11       Impact factor: 3.284

4.  Role of CD47 and Signal Regulatory Protein Alpha (SIRPα) in Regulating the Clearance of Viable or Aged Blood Cells.

Authors:  Oldenborg Per-Arne
Journal:  Transfus Med Hemother       Date:  2012-09-17       Impact factor: 3.747

5.  Selenium acts as an insulin-like molecule for the down-regulation of diabetic symptoms via endoplasmic reticulum stress and insulin signalling proteins in diabetes-induced non-obese diabetic mice.

Authors:  Daeyoun Hwang; Sujin Seo; Yongkyu Kim; Chuelkyu Kim; Sunbo Shim; Seungwan Jee; Suhae Lee; Mikyong Jang; Minsun Kim; Suyoun Yim; Sang-Koo Lee; Byeongcheol Kang; Insurk Jang; Jungsik Cho
Journal:  J Biosci       Date:  2007-06       Impact factor: 1.826

6.  B cells in autoimmune diabetes.

Authors:  F Susan Wong; Li Wen
Journal:  Rev Diabet Stud       Date:  2005-11-10

7.  Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice.

Authors:  D L Greiner; L D Shultz; J Yates; M C Appel; G Perdrizet; R M Hesselton; I Schweitzer; W G Beamer; K L Shultz; S C Pelsue
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

8.  Mycobacteria, an environmental enhancer of lupus nephritis in a mouse model of systemic lupus erythematosus.

Authors:  Christine G Hawke; Dorothy M Painter; Paul D Kirwan; Rosemary R Van Driel; Alan G Baxter
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

9.  Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice.

Authors:  A G Baxter; A C Horsfall; D Healey; P Ozegbe; S Day; D G Williams; A Cooke
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

10.  Characterization and specificity of B-cell responses in lupus induced by Mycobacterium bovis in NOD/Lt mice.

Authors:  A C Horsfall; R Howson; P Silveira; D G Williams; A G Baxter
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.